Business Context and Reporting Period
Pavmed Inc. (PAVM), a Delaware corporation and emerging growth company, filed this Form 8-K on March 5, 2018. The report addresses a regulatory notice received from The Nasdaq Stock Market regarding the company's compliance with listing standards.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the Market Value of Listed Securities (MVLS), which fell below the required minimum of $35 million for 30 consecutive business days through March 2, 2018.
Material Changes
The primary material event is the receipt of a Nasdaq deficiency notice under Listing Rule 5550(b)(2). The company's MVLS failed to meet the $35 million threshold required for continued inclusion on the Nasdaq Capital Market. This represents a deviation from the minimum listing standards but does not constitute an immediate delisting.
Outlook, Risks, and Management Commentary
- Compliance Period: Nasdaq has granted the company 180 calendar days (until September 4, 2018) to regain compliance.
- Compliance Requirement: To cure the deficiency, the MVLS must remain at or above $35 million for a minimum of ten consecutive business days.
- Trading Status: The notice has no immediate effect on trading; common stock and warrants will continue to trade under symbols "PAVM" and "PAVMW".
- Risk of Delisting: If the company fails to regain compliance within the 180-day window, its securities may be subject to delisting.
- Management Action: The company intends to consider all available options to restore compliance.
Investor Verification Checklist
- Verify the current Market Value of Listed Securities (MVLS) to assess proximity to the $35 million threshold.
- Monitor the company's stock price volatility over the next 180 days to determine the feasibility of meeting the 10-day compliance window.
- Review subsequent filings for any announced capital raising activities or strategic actions intended to increase market value.
- Confirm the continued trading status of PAVM and PAVMW on Nasdaq.